![Hatice Bölek’s remarkable work on our latest study on Prognostic Perception and QOL in Metastatic Renal and Bladder Cancer](https://oncodaily.com/pub/uploads/2024/09/Untitled-design-1280x960.jpg)
Hatice Bölek’s remarkable work on our latest study on Prognostic Perception and QOL in Metastatic Renal and Bladder Cancer
Yüksel Ürün shared on X:
“Huge congratulations to Hatice Bölek a rising star in oncology, for her remarkable work on our latest study in JCO Global Oncology!
While many mRCC/mBC patients remain optimistic, this often leads to inaccurate cure beliefs. Enhancing communication about prognosis is crucial for aligning patient expectations with clinical realities.”
Authors: Hatice Bolek, MD, Cagatay Arslan, MD, Mert Basaran, MD, İrfan Cicin, MD, Mustafa Ozguroglu, MD, Deniz Tural, MD, and Yüksel Ürün, MD
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023